Remarkable reduction of MAP2 in the brains of scrapie-infected rodents and human prion disease possibly correlated with the increase of calpain

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Guo, Yan ^a   Gong, Han Shi ^a   Zhang, Jin ^a   Xie, Wu Ling ^a   Tian, Chan ^a   Chen, Cao ^a   Shi, Qi ^a   Wang, Shao Bin ^a   Xu, Yin ^a   Zhang, Bao Yun ^a   Dong, Xiao Ping ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CALPAIN; MICROTUBULE ASSOCIATED PROTEIN 2; PRION PROTEIN; TUBULIN; MICROTUBULE ASSOCIATED PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DOWN REGULATION; FATAL FAMILIAL INSOMNIA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCUBATION TIME; MICROTUBULE; NEUROBLASTOMA CELL; NONHUMAN; PRION DISEASE; SCRAPIE; SYRIAN HAMSTER; WESTERN BLOTTING; ADULT; AMINO ACID SEQUENCE; ANIMAL; BRAIN; CELL SURVIVAL; CONFOCAL MICROSCOPY; DOSE RESPONSE; DRUG EFFECT; FEMALE; HAMSTER; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; PATHOLOGY; RODENT DISEASE; TUMOR CELL LINE;

CRICETINAE; RODENTIA;

ADULT; AMINO ACID SEQUENCE; ANIMALS; BLOTTING, WESTERN; BRAIN; CALPAIN; CELL LINE, TUMOR; CELL SURVIVAL; CREUTZFELDT-JAKOB SYNDROME; CRICETINAE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INSOMNIA, FATAL FAMILIAL; MESOCRICETUS; MICROSCOPY, CONFOCAL; MICROTUBULE-ASSOCIATED PROTEINS; MICROTUBULES; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PRION DISEASES; PRPSC PROTEINS; RODENT DISEASES; SCRAPIE;

EID: 84855822399     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030163     Document Type: Article

References (43)

1. Prusiner SB, (1998) Prions. Proc Natl Acad Sci U S A 95: 13363-13383.
2. Collinge J, (2001) Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 24: 519-550.
3. Legname G, Baskakov IV, Nguyen HO, Riesner D, Cohen FE, et al. (2004) Synthetic mammalian prions. Science 305: 673-676.
4. Forloni G, Angeretti N, Chiesa R, Monzani E, Salmona M, et al. (1993) Neurotoxicity of a prion protein fragment. Nature 362: 543-546.
5. Seo JS, Moon MH, Jeong JK, Seol JW, Lee YJ, et al. (2010) SIRT1, a histone deacetylase, regulates prion protein-induced neuronal cell death. Neurobiol Aging.
6. Ettaiche M, Pichot R, Vincent JP, Chabry J, (2000) In vivo cytotoxicity of the prion protein fragment 106-126. J Biol Chem 275: 36487-36490.
7. Selvaggini C, De Gioia L, Cantu L, Ghibaudi E, Diomede L, et al. (1993) Molecular characteristics of a protease-resistant, amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein. Biochem Biophys Res Commun 194: 1380-1386.
8. Mollinedo F, Gajate C, (2003) Microtubules, microtubule-interfering agents and apoptosis. Apoptosis 8: 413-450.
9. Yamaguchi S, Fujii-Taira I, Murakami A, Hirose N, Aoki N, et al. (2008) Up-regulation of microtubule-associated protein 2 accompanying the filial imprinting of domestic chicks (Gallus gallus domesticus). Brain Res Bull 76: 282-288.
10. Dehmelt L, Halpain S, (2005) The MAP2/Tau family of microtubule-associated proteins. Genome Biol 6: 204.
11. Adlard PA, Vickers JC, (2002) Morphologically distinct plaque types differentially affect dendritic structure and organisation in the early and late stages of Alzheimer's disease. Acta Neuropathol 103: 377-383.
12. Hsia AY, Masliah E, McConlogue L, Yu GQ, Tatsuno G, et al. (1999) Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc Natl Acad Sci U S A 96: 3228-3233.
13. Fifre A, Sponne I, Koziel V, Kriem B, Yen Potin FT, et al. (2006) Microtubule-associated protein MAP1A, MAP1B, and MAP2 proteolysis during soluble amyloid beta-peptide-induced neuronal apoptosis. Synergistic involvement of calpain and caspase-3. J Biol Chem 281: 229-240.
14. Xiao Z, Lin L, Liu Z, Ji F, Shao W, et al. (2010) Potential therapeutic effects of curcumin: relationship to microtubule-associated proteins 2 in Abeta1-42 insult. Brain Res 1361: 115-123.
15. Zhou RM, Jing YY, Guo Y, Gao C, Zhang BY, et al. (2011) Molecular interaction of TPPP with PrP antagonized the CytoPrP-induced disruption of microtubule structures and cytotoxicity. PLoS ONE 6: e23079.
16. Li XL, Wang GR, Jing YY, Pan MM, Dong CF, et al. (2011) Cytosolic PrP induces apoptosis of cell by disrupting microtubule assembly. J Mol Neurosci 43: 316-325.
17. Osiecka KM, Nieznanska H, Skowronek KJ, Karolczak J, Schneider G, et al. (2009) Prion protein region 23-32 interacts with tubulin and inhibits microtubule assembly. Proteins 77: 279-296.
18. Dong CF, Shi S, Wang XF, An R, Li P, et al. (2008) The N-terminus of PrP is responsible for interacting with tubulin and fCJD related PrP mutants possess stronger inhibitive effect on microtubule assembly in vitro. Arch Biochem Biophys 470: 83-92.
19. Shi Q, Zhang BY, Gao C, Han J, Wang GR, et al. (2011) The diversities of PrP(Sc) distributions and pathologic changes in various brain regions from a Chinese patient with G114V genetic CJD. Neuropathology.
20. Shi XH, Han J, Zhang J, Shi Q, Chen JM, et al. (2010) Clinical, histopathological and genetic studies in a family with fatal familial insomnia. Infect Genet Evol 10: 292-297.
21. Yao HL, Han J, Gao JM, Zhang J, Zhang BY, et al. (2005) Comparative study of the effects of several chemical and physical treatments on the activity of protease resistance and infectivity of scrapie strain 263K. J Vet Med B Infect Dis Vet Public Health 52: 437-443.
22. Shafit-Zagardo B, Kalcheva N, (1998) Making sense of the multiple MAP-2 transcripts and their role in the neuron. Mol Neurobiol 16: 149-162.
23. Tucker RP, (1990) The roles of microtubule-associated proteins in brain morphogenesis: a review. Brain Res Brain Res Rev 15: 101-120.
24. Sanchez C, Diaz-Nido J, Avila J, (2000) Phosphorylation of microtubule-associated protein 2 (MAP2) and its relevance for the regulation of the neuronal cytoskeleton function. Prog Neurobiol 61: 133-168.
25. Riederer B, Matus A, (1985) Differential expression of distinct microtubule-associated proteins during brain development. Proc Natl Acad Sci U S A 82: 6006-6009.
26. Nukina N, Ihara Y, (1986) One of the antigenic determinants of paired helical filaments is related to tau protein. J Biochem 99: 1541-1544.
27. Gao JM, Gao C, Han J, Zhou XB, Xiao XL, et al. (2004) Dynamic analyses of PrP and PrP(Sc) in brain tissues of golden hamsters infected with scrapie strain 263K revealed various PrP forms. Biomed Environ Sci 17: 8-20.
28. Springer JE, Azbill RD, Kennedy SE, George J, Geddes JW, (1997) Rapid calpain I activation and cytoskeletal protein degradation following traumatic spinal cord injury: attenuation with riluzole pretreatment. J Neurochem 69: 1592-1600.
29. Brown DR, Schmidt B, Kretzschmar HA, (1998) Prion protein fragment interacts with PrP-deficient cells. J Neurosci Res 52: 260-267.
30. McHattie SJ, Brown DR, Bird MM, (1999) Cellular uptake of the prion protein fragment PrP106-126 in vitro. J Neurocytol 28: 149-159.
31. Brown DR, (2000) Altered toxicity of the prion protein peptide PrP106-126 carrying the Ala(117)-&Val mutation. Biochem J 346 Pt 3: 785-791.
32. Han J, Zhang J, Yao H, Wang X, Li F, et al. (2006) Study on interaction between microtubule associated protein tau and prion protein. Sci China C Life Sci 49: 473-479.
33. Zhou R-M, Jing Y-Y, Gao C, Guo Y, (2011) Molecular interaction of TPPP with PrP antagonized the CytoPrP-induced disruption of microtubule structures and cytotoxicity. PLoS ONE 26: 379-386.
34. Ebneth A, Godemann R, Stamer K, Illenberger S, Trinczek B, et al. (1998) Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease. J Cell Biol 143: 777-794.
35. Bertipaglia I, Carafoli E, (2007) Calpains and human disease. Subcell Biochem 45: 29-53.
36. Chan SL, Mattson MP, (1999) Caspase and calpain substrates: roles in synaptic plasticity and cell death. J Neurosci Res 58: 167-190.
37. Dewar D, Dawson DA, (1997) Changes of cytoskeletal protein immunostaining in myelinated fibre tracts after focal cerebral ischaemia in the rat. Acta Neuropathol 93: 71-77.
38. Irving EA, McCulloch J, Dewar D, (1996) Intracortical perfusion of glutamate in vivo induces alterations of tau and microtubule-associated protein 2 immunoreactivity in the rat. Acta Neuropathol 92: 186-196.
39. Lopes JP, Oliveira CR, Agostinho P, (2007) Role of cyclin-dependent kinase 5 in the neurodegenerative process triggered by amyloid-Beta and prion peptides: implications for Alzheimer's disease and prion-related encephalopathies. Cell Mol Neurobiol 27: 943-957.
40. Rao MV, Mohan PS, Peterhoff CM, Yang DS, Schmidt SD, et al. (2008) Marked calpastatin (CAST) depletion in Alzheimer's disease accelerates cytoskeleton disruption and neurodegeneration: neuroprotection by CAST overexpression. J Neurosci 28: 12241-12254.
41. O'Donovan CN, Tobin D, Cotter TG, (2001) Prion protein fragment PrP-(106-126) induces apoptosis via mitochondrial disruption in human neuronal SH-SY5Y cells. J Biol Chem 276: 43516-43523.
42. LaFerla FM, (2002) Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease. Nat Rev Neurosci 3: 862-872.
43. Vanderklish PW, Bahr BA, (2000) The pathogenic activation of calpain: a marker and mediator of cellular toxicity and disease states. Int J Exp Pathol 81: 323-339.